Rhenman & Partners Asset Management’s Charles River Laboratories CRL Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$4.39M	Buy
2025 Q1	–	Sell
2024 Q4	$2.74M	Sell
2024 Q3	$7.39M	Buy
2024 Q2	$7.02M	Buy
2024 Q1	$3.44M	Sell
2023 Q4	$8.98M	Sell
2023 Q3	$8.62M	Buy